$6.95
0.213.12%
At close: -
$7.19
0.243.45%
After Hours: 4:47 PM EDT
Vir Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vir Biotechnology using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $-1.56 | $-1.05 | -48.6 % |
Jun 2024 | 2024-08-01 | $-1.02 | $-0.89 | -14.6 % |
Mar 2024 | 2024-05-02 | $-0.48 | $-1.05 | 54.3 % |
Dec 2023 | 2024-02-22 | $-0.86 | $-1.01 | 14.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $2.38M | $5.51M | -56.8 % |
Jun 2024 | 2024-08-01 | $3.08M | $7.50M | -59.0 % |
Dec 2023 | 2024-02-22 | $16.79M | $12.15M | 38.2 % |
Sep 2023 | 2023-11-02 | $2.64M | $10.24M | -74.2 % |
Vir Biotechnology (VIR) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $-1.56, which missed the estimate of $-1.05.
The Actual Revenue was $2.4M, which missed the estimate of $5.5M.
Browse earnings estimates, EPS, and revenue on all stocks.